LMR Partners »

Tscan Therapeutics shares owned by LMR Partners

Quarter-by-quarter ownership of Tscan Therapeutics (TCRX) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Tscan Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tscan Therapeutics held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tscan Therapeutics by LMR Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.9M 666k 5.85

More positions owned by LMR Partners

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation (NVDA)
Microstrategy Cl A New Put Option (MSTR)
Apple (AAPL)
Advanced Micro Devices (AMD)
Ishares Tr National Mun Etf (MUB)
Pdd Holdings Sponsored Ads (PDD)
GSK Sponsored Adr (GSK)
BP Sponsored Adr (BP)
United States Steel Corporation (X)
Hdfc Bank Sponsored Ads (HDB)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Stellantis SHS Put Option (STLA)
International Paper Company Call Option (IP)

View all positions for LMR Partners

Top funds holding Tscan Therapeutics

Lynx1 Capital Management
EcoR1 Capital
BlackRock
BVF
Baker Bros. Advisors
Vanguard Group
Propel Bio Management
Deer Management
Alphabet
Simplify Asset Management
Dr. Jeffrey R. Jay, M.D.
Geode Capital Management
Stempoint Capital
LMR Partners
DC Funds

View all funds holding Tscan Therapeutics